A team of UCF researchers has demonstrated the effectiveness of a nanomaterial-based anti-infective (Researchers show that this intermediary) drug it developed to combat the spread of the COVID-19 virus. Through their experiments, they found that antibiotics can kill many serious viruses, including SARS and Zika.
The results of their findings were recently published in ACS Applied Materials and Interfaces.
“It’s always a pleasure to see our research published in a prestigious journal,” said Udit Kumar, PhD student in the Department of Materials Science and Engineering (MSE) and lead author of the paper. says the report. “Given the topic and its potential impact on current antivirus research, our article will certainly help fight against the global epidemic.”
This report describes a new study by a group of researchers including Sudipta Seal, chair of the MSE department, and Griff Parks, virologist in the College of Medicine and director of the Burnett School of Biomedical Sciences. They tried nanomaterial yttrium silicate, which has antibacterial (Researchers show that this intermediary) properties that work with white light, such as sunlight or light. As long as there is a continuous fire, the disinfectants regenerate, creating a self-cleaning surface.
“Yttrium silicate acts as a silent killer, with an anti-bacterial property that transmits light continuously,” says Kumar. “It’s more effective in reducing the spread of many surface-to-surface pathogens.”
Kumar said that their white yttrium silicate test removes the most contaminated material in about 30 minutes. Also, the nanomaterial can fight the spread of other viruses, including para influenza, vesicular stomatitis, rhinovirus, Zika, and SARS. Seal says,
“This antibiotic technology is a huge engineering feat in health care because we’ve all been affected by this pandemic.” “Covid is still going strong and who knows what other diseases are on the horizon.”
Other UCF researchers, including College of Medicine postdoctoral researcher Candace Fox ’16MS ’19PhD, nanotechnology student Balaashwin Babu ’20, and materials science and engineering student Erik Marcelo, are co-authors of things.
“This paper is the culmination of a period of understanding by researchers about the need to accelerate the development of broad-spectrum antimicrobial, as well as hard work in the laboratory to demonstrate the power of our innovations,” said Parks. “It is an excellent example of self-reliance – and that, researchers and rats in the microbiology of COC and com.”
